Area of research
Genetics · Hematology
Research interest
Research interests include Hemoglobinopathies and Related Disorders, Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, and Chronic Lymphocytic Leukemia Research.
Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts
Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial
The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions